Mono Pharmacare Ltd

Mono Pharmacare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Mono Pharmacare Ltd

₹ 11.0 0.45%
11 Mar 10:59 a.m.
monopharmacareltd.com NSE - SME: MONOPHARMA
About

Incorporated in 1994, Mono Pharmacare Ltd is in the business of distribution of Pharmaceutical items[1]

Key Points

Business Overview:[1]
MPL is a distributor and supplier of a wide array of pharmaceutical products and medicines. It offers
Health Care Products, Antibiotic medicines, Cough Cold Anti-Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid
& Antiemetic medicines, Cardiac – Diabetic medicines, and Cosmo care products.

Website NSE - SM
  • Market Cap ₹ 19.5 Cr.
  • Current Price ₹ 11.0
  • High / Low ₹ 28.9 / 9.45
  • Stock P/E 23.5
  • Book Value ₹ 17.7
  • Dividend Yield 0.00 %
  • ROCE 11.0 %
  • ROE 10.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.62 times its book value
  • Debtor days have improved from 160 to 90.8 days.
  • Company's working capital requirements have reduced from 217 days to 120 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 9.77% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025
35 67 56 87 81 66
33 63 53 82 78 65
Operating Profit 2 4 2 5 3 2
OPM % 6% 6% 4% 5% 4% 3%
0 0 0 0 1 0
Interest 1 2 2 2 2 2
Depreciation 0 0 0 0 0 0
Profit before tax 1 2 1 3 1 0
Tax % 39% 20% 33% 27% 37% 83%
1 2 1 2 1 0
EPS in Rs 0.52 1.06 0.33 1.30 0.46 0.01
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 TTM
27 122 168 147
25 116 161 143
Operating Profit 2 6 8 5
OPM % 6% 5% 5% 3%
0 0 1 1
Interest 1 3 4 4
Depreciation 0 0 0 0
Profit before tax 1 3 4 1
Tax % 25% 24% 30%
1 2 3 1
EPS in Rs 0.57 1.38 1.75 0.47
Dividend Payout % 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 3%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -71%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -60%
Return on Equity
10 Years: %
5 Years: %
3 Years: 10%
Last Year: 10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 12 18 18 18
Reserves 1 10 14 14
40 41 54 55
9 12 25 33
Total Liabilities 63 81 110 119
1 1 1 1
CWIP 0 0 0 0
Investments 1 0 0 0
61 80 109 118
Total Assets 63 81 110 119

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
-28 -9 -4
-1 0 -0
30 8 5
Net Cash Flow 0 -0 0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
Debtor Days 296 94 91
Inventory Days 497 139 133
Days Payable 103 32 45
Cash Conversion Cycle 689 202 179
Working Capital Days 399 131 120
ROCE % 10% 11%

Insights

In beta
Mar 2023Mar 2024Mar 2025
Net Capital Turnover Ratio (Consolidated)
Times

Log in to view insights

Please log in to see hidden values.

Login
Net Capital Turnover Ratio (Standalone)
Times ・Standalone data
Trade Payable Turnover Ratio (Consolidated)
Times
Trade Payable Turnover Ratio (Standalone)
Times ・Standalone data
Trade Receivable Turnover Ratio (Consolidated)
Times
Trade Receivable Turnover Ratio (Standalone)
Times ・Standalone data
Number of Employees
Number ・Standalone data

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Sep 2024Mar 2025Sep 2025
56.72% 56.72% 56.72% 56.72% 56.72% 56.72%
43.28% 43.27% 43.28% 43.28% 43.28% 43.28%
No. of Shareholders 621528418463478514

Documents

Announcements

Annual reports